Cold News and Research

RSS

High resolution single tube reader

Ziath announce the Uno single tube reader – a powerful device packed with exciting features to make your sample management work with 2D barcoded tubes easier and faster.

From Ziath Ltd 12 Jan 2022

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

A new study, posted to the medRxiv* preprint server, has focussed on the development of intranasal prophylaxis against SARS-CoV-2 infection.

11 Jan 2022

A common cold may boost the immune system against COVID-19

A recent groundbreaking research paper published in the journal Nature Communications reveals the association of circulating SARS-CoV-2-specific T cells at exposure with lack of infection – implying the protective role for cross-reactive immune T cells in coronavirus disease 2019 (COVID-19) and opening the door for second-generation vaccines that could circumvent spike-antibody immune escape variants.

11 Jan 2022

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Preliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability and feasibility of chimeric antigen receptor macrophage (CAR-M) has helped to establish the viability of this innovative immunotherapy, which advances the trailblazing scientific discovery of CAR T cell therapy- also pioneered at Penn- for solid cancer tumors and offers a promising new strategy in the fight against cancer.

11 Jan 2022

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

A team of researchers recently analyzed differential protein glyco-isoform distributions of symptomatic and asymptomatic coronavirus disease 2019 patients.

11 Jan 2022

Secondhand nicotine vaping at home may increase risk of bronchitic symptoms in young adults

Secondhand exposure at home to the nicotine vapour from e-cigarettes is linked to a heightened risk of bronchitic symptoms and shortness of breath among young adults, finds research published online in the respiratory journal Thorax.

11 Jan 2022

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells.

10 Jan 2022

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Researchers from India have now successfully grown and isolated the Omicron variant from hamsters in vivo with further culturing in the Vero CCL-81 cells in vitro, in a step forward towards testing the effectiveness of existing SARS-CoV-2 vaccines and generation of new Omicron appropriate vaccines.

7 Jan 2022

Research uncovers how a mouse brain understands sensory information

The brain is the most complex organ in our body – constantly absorbing and interpreting our surroundings, and guiding our movement, thoughts, behaviors and emotions.

6 Jan 2022

PLOS and CSHL expand partnership to offer new options for sharing preprints in medicine

The Public Library of Science (PLOS) and Cold Spring Harbor Laboratory (CSHL) today announced an expansion of their longstanding partnership to offer authors more options for rapidly and easily sharing their research before publication in a journal.

6 Jan 2022

Emotional response can fuel the spread of "fake news"

From Facebook feeds to questionable websites, so-called "fake news" is seemingly everywhere. When it comes to the misleading information, our emotional response to seeing it can actually further its spread, according to a Bowling Green State University researcher.

6 Jan 2022

Echinacea, a potent antiviral against SARS-CoV-2

Researchers present available evidence on the activity of Echinacea purpure against coronavirus infections.

3 Jan 2022

WHO lists the Comirnaty COVID-19 mRNA vaccine for emergency use

The World Health Organization today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.

2 Jan 2022

Children with pre-existing immunity to common cold demonstrate better protection against COVID-19

New data shows that, compared to adults, children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially activate pre-existing acquired immunity to prevalent common cold coronaviruses that cross-react with SARS-CoV-2 and protect them from severe disease.

24 Dec 2021

World leaders meet to discuss about COVID-19 vaccines, therapeutics and diagnostics

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization held high-level consultations with Gavi and UNICEF on 17 December, 2021 aimed at increasing the use of COVID-19 vaccines and other critical medical countermeasures in low-income (LIC) and lower middle-income (LMIC) countries and supporting countries to be better prepared, resourced, and ready to roll out vaccines.

22 Dec 2021

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

A recent review article discusses recent advances in protein-based nanoparticle vaccines against SARS-CoV-2.

22 Dec 2021

Investigating potential cross-protection against SARS-CoV-2 after previous exposure to bovine coronavirus

Researchers have conducted an investigation to probe the similarity of viral epitopes between bovine coronavirus (BCoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Dec 2021

A Day in the Life of a Thoracic and Cardiovascular Surgeon

In this interview, we spoke to Dr. Alexander Marmureanu, a thoracic and cardiovascular surgeon, about his day-to-day role and responsibilities as well as his career highlights.

17 Dec 2021

Nanoparticle therapeutic can be a potential new approach for treating malignant pleural effusion

Researchers at Wake Forest School of Medicine have discovered that a nanoparticle therapeutic enhances cancer immunotherapy and is a possible new approach in treating malignant pleural effusion (MPE).

16 Dec 2021

Omicron is more transmissible but may have milder symptoms for many people, expert says

If the first reports coming out of South Africa are correct, Omicron might be more transmissible than the current dominant Covid-19 strain, Delta, but cause less severe symptoms for many people. A leading expert says that, if the new strain does turn out to be milder for some people, that creates a new set of problems.

16 Dec 2021

Cold News and Research

High resolution single tube reader

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

A common cold may boost the immune system against COVID-19

Phase 1 clinical trial shows the safety, feasibility of CAR-M cell therapy for solid tumors

Mapping peripheral blood glycoprotein profiles of COVID-19 patients

Secondhand nicotine vaping at home may increase risk of bronchitic symptoms in young adults

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Research uncovers how a mouse brain understands sensory information

PLOS and CSHL expand partnership to offer new options for sharing preprints in medicine

Emotional response can fuel the spread of "fake news"

Echinacea, a potent antiviral against SARS-CoV-2

WHO lists the Comirnaty COVID-19 mRNA vaccine for emergency use

Children with pre-existing immunity to common cold demonstrate better protection against COVID-19

World leaders meet to discuss about COVID-19 vaccines, therapeutics and diagnostics

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

Investigating potential cross-protection against SARS-CoV-2 after previous exposure to bovine coronavirus

A Day in the Life of a Thoracic and Cardiovascular Surgeon

Nanoparticle therapeutic can be a potential new approach for treating malignant pleural effusion

Omicron is more transmissible but may have milder symptoms for many people, expert says

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News